Matches in Wikidata for { <http://www.wikidata.org/entity/Q66058992> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q66058992 description "assaig clínic" @default.
- Q66058992 description "clinical trial" @default.
- Q66058992 description "clinical trial" @default.
- Q66058992 description "clinical trial" @default.
- Q66058992 description "clinical trial" @default.
- Q66058992 description "ensaio clínico" @default.
- Q66058992 description "ensayo clínico" @default.
- Q66058992 description "ensayu clínicu" @default.
- Q66058992 description "essai clinique" @default.
- Q66058992 description "klinisch onderzoek" @default.
- Q66058992 description "клінічне випробування" @default.
- Q66058992 name "A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression" @default.
- Q66058992 name "A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression" @default.
- Q66058992 type Item @default.
- Q66058992 label "A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression" @default.
- Q66058992 label "A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression" @default.
- Q66058992 prefLabel "A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression" @default.
- Q66058992 prefLabel "A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression" @default.
- Q66058992 P1132 Q66058992-8404690A-EA68-42D1-93A3-122E7C1E3CF2 @default.
- Q66058992 P1476 Q66058992-45FD4BD7-74F8-41DE-9B18-D41BF9DB0A0D @default.
- Q66058992 P17 Q66058992-EB5CD687-5693-4A13-8358-B35D112276FF @default.
- Q66058992 P2899 Q66058992-88ADC53D-C3CC-472A-9F67-C1B7109805A7 @default.
- Q66058992 P3098 Q66058992-03BF1ECC-17D7-432E-AFDA-F81C767922FA @default.
- Q66058992 P31 Q66058992-1437C8C3-0AD1-470F-9C26-21C061DE1A09 @default.
- Q66058992 P4135 Q66058992-3C92A69E-253A-4712-B8E5-D431D2F7A940 @default.
- Q66058992 P580 Q66058992-216E5D6B-DA89-4B99-84EF-83B7EC2EB865 @default.
- Q66058992 P582 Q66058992-69DFF04A-7D01-405D-BCD7-D2D329169F76 @default.
- Q66058992 P6099 Q66058992-73D1F890-BC17-4ACA-88F2-A891A6172180 @default.
- Q66058992 P6153 Q66058992-13F34309-AE73-4DC0-954D-837C6D74CB1D @default.
- Q66058992 P6153 Q66058992-8EEDD78B-8EC1-42DC-8026-1577C6AC59CB @default.
- Q66058992 P6153 Q66058992-F65653CC-8B49-4C37-A79A-5341CA70A65E @default.
- Q66058992 P8363 Q66058992-A5CB4D0B-6ECC-4703-8C92-69969E3330F0 @default.
- Q66058992 P921 Q66058992-E04F8198-8068-47F9-8A81-C267A40FB625 @default.
- Q66058992 P1132 "+443" @default.
- Q66058992 P1476 "A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of Three Dose Levels of CORLUX™ (Mifepristone) Plus an Antidepressant vs. Placebo Plus an Antidepressant in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features (PMD)" @default.
- Q66058992 P17 Q30 @default.
- Q66058992 P2899 "+18" @default.
- Q66058992 P3098 "NCT00128479" @default.
- Q66058992 P31 Q30612 @default.
- Q66058992 P4135 "+75" @default.
- Q66058992 P580 "2004-09-01T00:00:00Z" @default.
- Q66058992 P582 "2007-01-01T00:00:00Z" @default.
- Q66058992 P6099 Q42824827 @default.
- Q66058992 P6153 Q1521725 @default.
- Q66058992 P6153 Q2725999 @default.
- Q66058992 P6153 Q30269791 @default.
- Q66058992 P8363 Q78089383 @default.
- Q66058992 P921 Q2914583 @default.